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Fibronectin Is Unsuitable as a Tumor Marker in Pleural Effusions
Patrick Deipuech, Gerard Deech, and Fabienne Fructus
We studied 75 patients with nonmalignant pleural effusions (50 with pneumopathy, 16 with pulmonary tuberculosis, and nine with congestive heart failure) and 33 patients with malignant pleural effusions. We selected 105 mg/L as the most suitable cutoff concentration of fibronectin for distinguishing between the two groups. We found high concentrations of fibronectin in 21 of the 33 patients with malignant pleural fluid but also in 37 of the 75 patients with nonmalignant pleural fluid. Evidently, measuring fibronectin in pleural fluid will not help in differentiating nonmalignant from malignant pleural fluids (diagnostic accuracy: 55%). The pleural-effusion samples were freshly collected in polystyrene test tubes and examined cytologically within 2 h of aspiration. The sediment obtained by centrifugation of 10-to 20-mL samples at 500 x g for 10 mm(5) was smeared onto microscope slides, stained with the Gram and ZiehiNeelsen stains, and examined. The corresponding supernates were used for biochemical analysis: total protein measurement by the sulfosalicylic acid method (6) and fibronectin measurement by an immunoturbiclimetric method (7) , in the Rotochem Ha (Roche Kontron) centrifugal analyzer. Reagents for fibronectin determination were obmined from Behring Diagnostics (Marburg, F.R.G.). Fibronectin antiserum (code no. OUND) was diluted fivefold with accelerator I (code no. OSVX) in isotonic sodium chloride (1:2). The reference curve was determined from a geometric dilution series of Protein Standard Plasma (code no. OTJID). Samples were diluted fourfold in isotonic NaC1. Kinetic turbidimetric measurement of the antigen-antibody reaction was recorded at 340 nm according to the principle of the fixed-time method (10 and 600 s).
The 16 patients with advanced pulmonary tuberculosis (category ifi of the American Thoracic Society) were positive for acid-fast bacilli in sputum before admission to the study; positive cultures were also confirmed six weeks later.
The data for the patients with nonmalignant pleural effusions and with low protein concentrations (<30 g/L) were used to determine the most suitable discriminating Results are reported as mean ± SD. To determine the significance of the results comparisons we used Student's two-tailed unpaired t-test, taking P = 0.001 as the minimum level of significance.
Results and Discussion
Success in the management of cancer patients depends greatly on the presence of tumor markers: to detect early cancer, to achieve more accurate staging, to monitor the response to treatment, and to discover recurrences earlier.
To our knowledge, there is little information about fibronectin in pleural effusions (2), so we have evaluated the diagnostic accuracy of this analyte in pleural fluids. In our study, we did not consider the possible variation of fibronectin concentrations with sex and age, as was reported for fibronectin in blood (9).
Congestive heart failure, cancer, pneumonia, pulmonary embolism, and pulmonary tuberculosis are common diseases that can cause pleural efusions. (Tables 1, 2) .
In our study, pleural fluid from the 16 patients with active advanced pulmonary tuberculosis was a serous exudate with high fibronectin content (Table 3) (11, 12) . Most probably, they accumulate as a (Table 3) . Table 2 followed by the same AlA analysis for progesterone in the dialysate. Despite the dramatic increases in concentrations of total progesterone and binding proteins in plasma during pregnancy, we found highly significant correlations between total and free progesterone in plasma and salivary progesterone in the group as a whole as well as individuals (P <0.001 in almost all cases). The proportion of free progesterone in plasma and of salivary progesterone relative to total progesterone in plasma remained constant at -1% and 0.5%, respectively, whereas during the postpartum period there was much more variance. Evidently salivary progesterone is a very good alternative to plasma as a sample for use in follow-up during pregnancy.
Since the discovery that steroid hormones are present and measurable in saliva (1), the clinical advantages of using this kind of sample for their determination have been
